NO20030033L - Pyrido[2,3-D]pyrimidin- og pyrimido[4,5-D]pyrimidin- nukleosider - Google Patents
Pyrido[2,3-D]pyrimidin- og pyrimido[4,5-D]pyrimidin- nukleosiderInfo
- Publication number
- NO20030033L NO20030033L NO20030033A NO20030033A NO20030033L NO 20030033 L NO20030033 L NO 20030033L NO 20030033 A NO20030033 A NO 20030033A NO 20030033 A NO20030033 A NO 20030033A NO 20030033 L NO20030033 L NO 20030033L
- Authority
- NO
- Norway
- Prior art keywords
- pyrimidine
- pyrimido
- pyrido
- nucleosides
- pyrimidine nucleosides
- Prior art date
Links
- UDJFFSGCRRMVFH-UHFFFAOYSA-N pyrido[2,3-d]pyrimidine Chemical compound N1=CN=CC2=CC=CN=C21 UDJFFSGCRRMVFH-UHFFFAOYSA-N 0.000 title 1
- 239000002718 pyrimidine nucleoside Substances 0.000 title 1
- QGDYVSSVBYMOJN-UHFFFAOYSA-N pyrimido[4,5-d]pyrimidine Chemical compound C1=NC=NC2=NC=NC=C21 QGDYVSSVBYMOJN-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21641800P | 2000-07-06 | 2000-07-06 | |
| PCT/US2001/041242 WO2002003997A1 (fr) | 2000-07-06 | 2001-07-03 | Nucleosides de pyrido[2,3-d]pyrimidine et de pyrimido[4,5-d]pyrimidine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20030033D0 NO20030033D0 (no) | 2003-01-03 |
| NO20030033L true NO20030033L (no) | 2003-01-03 |
Family
ID=22806989
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20030033A NO20030033L (no) | 2000-07-06 | 2003-01-03 | Pyrido[2,3-D]pyrimidin- og pyrimido[4,5-D]pyrimidin- nukleosider |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7081449B2 (fr) |
| EP (1) | EP1303282A4 (fr) |
| JP (1) | JP2004522694A (fr) |
| KR (1) | KR20030032944A (fr) |
| CN (1) | CN1440292A (fr) |
| AU (2) | AU2001273670B2 (fr) |
| BR (1) | BR0111531A (fr) |
| CA (1) | CA2405798A1 (fr) |
| CZ (1) | CZ20024052A3 (fr) |
| HU (1) | HUP0301614A3 (fr) |
| IL (1) | IL151849A0 (fr) |
| MX (1) | MXPA02012156A (fr) |
| NO (1) | NO20030033L (fr) |
| NZ (1) | NZ521457A (fr) |
| PL (1) | PL359559A1 (fr) |
| SK (1) | SK112003A3 (fr) |
| UA (1) | UA72612C2 (fr) |
| WO (1) | WO2002003997A1 (fr) |
| ZA (1) | ZA200208010B (fr) |
Families Citing this family (74)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100974917B1 (ko) | 2000-04-13 | 2010-08-09 | 파마셋 인코포레이티드 | 간염 바이러스 감염 치료를 위한 3'- 또는2'-하이드록시메틸 치환된 뉴클레오시드 유도체 |
| MY164523A (en) | 2000-05-23 | 2017-12-29 | Univ Degli Studi Cagliari | Methods and compositions for treating hepatitis c virus |
| BR0111196A (pt) | 2000-05-26 | 2004-04-06 | Idenix Cayman Ltd | Composições e uso das mesmas para tratamento de flavivìrus e pestivìrus |
| US20060115815A1 (en) * | 2002-04-26 | 2006-06-01 | Gabriel Birkus | Method and compositions for identifying anti-hiv therapeutic compounds |
| CN101172993A (zh) | 2002-06-28 | 2008-05-07 | 埃迪尼克斯(开曼)有限公司 | 用于治疗黄病毒感染的2′－c－甲基－3′－o－l－缬氨酸酯核糖呋喃基胞苷 |
| AU2003248748A1 (en) | 2002-06-28 | 2004-01-19 | Idenix (Cayman) Limited | 2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
| IL166640A0 (en) | 2002-08-01 | 2006-01-15 | Pharmasset Ltd | Compounds with the bicyclo Ä4.2.1Ü nonane system for the treatment of flaviviridae infections |
| HUE033832T2 (en) | 2002-11-15 | 2018-01-29 | Idenix Pharmaceuticals Llc | 2'-methyl nucleosides in combination with interferon and Flaviviridae mutation |
| ES2470771T3 (es) | 2002-12-12 | 2014-06-24 | Idenix Pharmaceuticals, Inc | Procedimiento para la producción de nucle�sidos ramificados en 2' |
| US7452901B2 (en) | 2003-04-25 | 2008-11-18 | Gilead Sciences, Inc. | Anti-cancer phosphonate analogs |
| US7470724B2 (en) | 2003-04-25 | 2008-12-30 | Gilead Sciences, Inc. | Phosphonate compounds having immuno-modulatory activity |
| EP1628685B1 (fr) | 2003-04-25 | 2010-12-08 | Gilead Sciences, Inc. | Analogues phosphonates antiviraux |
| US7432261B2 (en) | 2003-04-25 | 2008-10-07 | Gilead Sciences, Inc. | Anti-inflammatory phosphonate compounds |
| US7407965B2 (en) | 2003-04-25 | 2008-08-05 | Gilead Sciences, Inc. | Phosphonate analogs for treating metabolic diseases |
| US7273716B2 (en) | 2003-04-25 | 2007-09-25 | Gilead Sciences, Inc. | Methods and compositions for identifying therapeutic compounds with GS-7340 ester hydrolase |
| WO2005002626A2 (fr) | 2003-04-25 | 2005-01-13 | Gilead Sciences, Inc. | Composes de phosphonate therapeutiques |
| EP1620109A2 (fr) | 2003-04-25 | 2006-02-01 | Gilead Sciences, Inc. | Analogues de phosphonate inhibiteurs de kinase |
| US7427636B2 (en) | 2003-04-25 | 2008-09-23 | Gilead Sciences, Inc. | Inosine monophosphate dehydrogenase inhibitory phosphonate compounds |
| US7300924B2 (en) | 2003-04-25 | 2007-11-27 | Gilead Sciences, Inc. | Anti-infective phosphonate analogs |
| US7550442B2 (en) * | 2003-05-20 | 2009-06-23 | The Board Of Trustees Of The University Of Illinois | Nucleoside analog inhibitors of reverse transcriptase |
| PL1633766T3 (pl) * | 2003-05-30 | 2019-09-30 | Gilead Pharmasset Llc | Modyfikowane fluorowane analogi nukleozydów |
| CA2533367C (fr) | 2003-07-25 | 2013-10-01 | Centre National De La Recherche Scientifique | Analogues des nucleosides puriques pour traiter flaviviridae et notamment l'hepatite cant l'hepatite c |
| US7432273B2 (en) | 2003-10-24 | 2008-10-07 | Gilead Sciences, Inc. | Phosphonate analogs of antimetabolites |
| WO2005044279A1 (fr) | 2003-10-24 | 2005-05-19 | Gilead Sciences, Inc. | Conjugues phosphonate / inhibiteur de purine nucleoside phosphorylase |
| EP1706405B1 (fr) | 2003-12-22 | 2009-03-04 | Gilead Sciences, Inc. | Derives de carbovir et d'abacavir 4'-substitues et composes associes dotes d'une activite antivirale dirigee contre le vih et le vhc |
| US20050182252A1 (en) | 2004-02-13 | 2005-08-18 | Reddy K. R. | Novel 2'-C-methyl nucleoside derivatives |
| JP4163738B2 (ja) * | 2004-06-11 | 2008-10-08 | 日本たばこ産業株式会社 | 癌の治療用の５−アミノ−２，４，７−トリオキソ−３，４，７，８−テトラヒドロ−２Ｈ−ピリド’２，３−ｄ！ピリミジン誘導体及び関連化合物 |
| US7378423B2 (en) | 2004-06-11 | 2008-05-27 | Japan Tobacco Inc. | Pyrimidine compound and medical use thereof |
| CN101023094B (zh) * | 2004-07-21 | 2011-05-18 | 法莫赛特股份有限公司 | 烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备 |
| CA2574514A1 (fr) | 2004-07-27 | 2006-10-19 | Gilead Sciences, Inc. | Analogues phosphonates de composes inhibiteurs du vih |
| BRPI0515279A (pt) | 2004-09-14 | 2008-07-15 | Pharmasset Inc | preparação de ribofuranosil pirimidinas e purinas 2'fluoro-2'-alquil- substituìdas ou outras opcionalmente substituìdas e seus derivados |
| AU2006222563A1 (en) * | 2005-03-08 | 2006-09-14 | Biota Scientific Management Pty Ltd. | Bicyclic nucleosides and nucleotides as therapeutic agents |
| US7951789B2 (en) * | 2006-12-28 | 2011-05-31 | Idenix Pharmaceuticals, Inc. | Compounds and pharmaceutical compositions for the treatment of viral infections |
| US7964580B2 (en) | 2007-03-30 | 2011-06-21 | Pharmasset, Inc. | Nucleoside phosphoramidate prodrugs |
| AU2008274956B2 (en) * | 2007-07-12 | 2014-08-21 | University Of South Florida | Inhibitors of Akt/PKB with anti-tumor activity |
| US8173621B2 (en) | 2008-06-11 | 2012-05-08 | Gilead Pharmasset Llc | Nucleoside cyclicphosphates |
| AU2009268681B2 (en) | 2008-07-08 | 2014-10-02 | Gilead Sciences, Inc. | Salts of HIV inhibitor compounds |
| CN102325783A (zh) | 2008-12-23 | 2012-01-18 | 法莫赛特股份有限公司 | 嘌呤核苷的合成 |
| ES2623016T3 (es) | 2008-12-23 | 2017-07-10 | Gilead Pharmasset Llc | Fosforamidatos de nucleósido de 2-amino purina 6-O-sustituida |
| JP6104504B2 (ja) | 2008-12-23 | 2017-03-29 | ギリアド ファーマセット エルエルシー | ヌクレオシド類似体 |
| MX2011009728A (es) | 2009-03-20 | 2011-10-14 | Alios Biopharma Inc | Analogos nucleotido y nucleosido sustituidos. |
| US8618076B2 (en) | 2009-05-20 | 2013-12-31 | Gilead Pharmasset Llc | Nucleoside phosphoramidates |
| TWI598358B (zh) | 2009-05-20 | 2017-09-11 | 基利法瑪席特有限責任公司 | 核苷磷醯胺 |
| MX350725B (es) | 2010-03-31 | 2017-09-14 | Gilead Pharmasset Llc | Fosforamidatos de nucleosido. |
| PL3290428T3 (pl) | 2010-03-31 | 2022-02-07 | Gilead Pharmasset Llc | Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu |
| AU2011305655B2 (en) | 2010-09-22 | 2015-11-05 | Alios Biopharma, Inc. | Substituted nucleotide analogs |
| WO2012158197A2 (fr) * | 2010-11-11 | 2012-11-22 | Lyndor Biosciences L.L.C. | Composés utiles en tant que modulateurs akt/pkb et leurs utilisations |
| WO2012075140A1 (fr) | 2010-11-30 | 2012-06-07 | Pharmasset, Inc. | Composés |
| NZ623396A (en) | 2011-09-16 | 2016-07-29 | Gilead Pharmasset Llc | Methods for treating hcv |
| US8889159B2 (en) | 2011-11-29 | 2014-11-18 | Gilead Pharmasset Llc | Compositions and methods for treating hepatitis C virus |
| WO2013096680A1 (fr) | 2011-12-22 | 2013-06-27 | Alios Biopharma, Inc. | Analogues de nucléotide phosphorothioate substitués |
| HUE041509T2 (hu) | 2011-12-22 | 2019-05-28 | Janssen Biopharma Inc | Szubsztituált nukleozidok, nukleotidok és ezek analógjai |
| KR102240101B1 (ko) * | 2012-03-14 | 2021-04-14 | 루핀 리미티드 | 헤테로사이클릴 화합물 |
| HK1206362A1 (zh) | 2012-03-21 | 2016-01-08 | Alios Biopharma, Inc. | 硫代氨基磷酸酯核苷酸前藥的固體形式 |
| USRE48171E1 (en) | 2012-03-21 | 2020-08-25 | Janssen Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| US9441007B2 (en) | 2012-03-21 | 2016-09-13 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| WO2013142157A1 (fr) | 2012-03-22 | 2013-09-26 | Alios Biopharma, Inc. | Combinaisons pharmaceutiques comprenant un analogue thionucléotidique |
| PL2861611T3 (pl) | 2012-05-25 | 2017-08-31 | Janssen Sciences Ireland Uc | Nukleozydy uracylowe spirooksetanu |
| CN102816197B (zh) * | 2012-08-24 | 2015-04-29 | 四川大学华西医院 | 一种新的嘧啶并嘧啶类核苷类似物、制备方法及其形成的超分子结构和应用 |
| WO2014100505A1 (fr) | 2012-12-21 | 2014-06-26 | Alios Biopharma, Inc. | Nucléosides, nucléotides substitués et leurs analogues |
| US20140212491A1 (en) | 2013-01-31 | 2014-07-31 | Gilead Pharmasset Llc | Combination formulation of two antiviral compounds |
| JP2016529293A (ja) | 2013-08-27 | 2016-09-23 | ギリアド ファーマセット エルエルシー | ２つの抗ウイルス化合物の組合せ製剤 |
| TW201524990A (zh) | 2013-10-11 | 2015-07-01 | Alios Biopharma Inc | 經取代之核苷、核苷酸及其類似物 |
| CN106061984A (zh) | 2014-02-13 | 2016-10-26 | 配体药物公司 | 前药化合物及其用途 |
| JP2017520545A (ja) | 2014-07-02 | 2017-07-27 | リガンド・ファーマシューティカルズ・インコーポレイテッド | プロドラッグ化合物およびそれらの使用 |
| SG10201810361TA (en) * | 2014-09-26 | 2018-12-28 | Riboscience Llc | 4'-vinyl substituted nucleoside derivatives as inhibitors of respiratory syncytial virus rna replication |
| PT3661937T (pt) | 2017-08-01 | 2021-09-24 | Gilead Sciences Inc | Formas cristalinas de ((s)-((((2r,5r)-5-(6-amino-9h-purin-9-il)-4-fluoro-2,5-dihidrofurano-2-il)oxi)metil)(fenoxi)fosforil)-l-alaninato de etil (gs-9131) para tratamento de infeções virais |
| CN111788196A (zh) | 2018-01-09 | 2020-10-16 | 配体药物公司 | 缩醛化合物及其治疗用途 |
| ES2968459T3 (es) | 2018-05-15 | 2024-05-09 | Illumina Inc | Composiciones y métodos para escisión química y desprotección de oligonucleótidos unidos a superficie |
| MA55556A (fr) | 2019-04-02 | 2022-02-09 | Aligos Therapeutics Inc | Composés ciblant prmt5 |
| CN111995649A (zh) * | 2020-04-09 | 2020-11-27 | 瀚海新拓(杭州)生物医药有限公司 | 一种蝶啶酮核苷酸类似物及其药物组合物、制备方法和医药用途 |
| US12252488B2 (en) | 2021-02-12 | 2025-03-18 | Nimbus Saturn, Inc. | HPK1 antagonists and uses thereof |
| WO2022187856A1 (fr) | 2021-03-05 | 2022-09-09 | Nimbus Saturn, Inc. | Antagonistes de hpk1 et leurs utilisations |
| US12071442B2 (en) | 2021-03-29 | 2024-08-27 | Nimbus Saturn, Inc. | Substituted pyrrolo[3,4-c]pyridines as HPK1 antagonists |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3423398A (en) * | 1965-05-10 | 1969-01-21 | Pfizer & Co C | Sangivamycin and derivatives thereof |
| DE3686150T2 (de) * | 1985-09-09 | 1993-03-04 | Teijin Ltd | Pyridopyrimidin-nukleotid-abkoemmlinge. |
| US5034393A (en) * | 1989-07-27 | 1991-07-23 | Dowelanco | Fungicidal use of pyridopyrimidine, pteridine, pyrimidopyrimidine, pyrimidopyridazine, and pyrimido-1,2,4-triazine derivatives |
-
2001
- 2001-03-07 UA UA2002119182A patent/UA72612C2/uk unknown
- 2001-07-03 CZ CZ20024052A patent/CZ20024052A3/cs unknown
- 2001-07-03 PL PL01359559A patent/PL359559A1/xx not_active Application Discontinuation
- 2001-07-03 JP JP2002508451A patent/JP2004522694A/ja not_active Withdrawn
- 2001-07-03 AU AU2001273670A patent/AU2001273670B2/en not_active Expired - Fee Related
- 2001-07-03 AU AU7367001A patent/AU7367001A/xx active Pending
- 2001-07-03 BR BR0111531-6A patent/BR0111531A/pt not_active IP Right Cessation
- 2001-07-03 WO PCT/US2001/041242 patent/WO2002003997A1/fr not_active Ceased
- 2001-07-03 IL IL15184901A patent/IL151849A0/xx unknown
- 2001-07-03 EP EP01952967A patent/EP1303282A4/fr not_active Withdrawn
- 2001-07-03 HU HU0301614A patent/HUP0301614A3/hu unknown
- 2001-07-03 CN CN01812327A patent/CN1440292A/zh active Pending
- 2001-07-03 CA CA002405798A patent/CA2405798A1/fr not_active Abandoned
- 2001-07-03 US US10/221,397 patent/US7081449B2/en not_active Expired - Fee Related
- 2001-07-03 SK SK11-2003A patent/SK112003A3/sk unknown
- 2001-07-03 KR KR1020027014601A patent/KR20030032944A/ko not_active Abandoned
- 2001-07-03 MX MXPA02012156A patent/MXPA02012156A/es unknown
- 2001-07-03 NZ NZ521457A patent/NZ521457A/en unknown
-
2002
- 2002-10-04 ZA ZA200208010A patent/ZA200208010B/en unknown
-
2003
- 2003-01-03 NO NO20030033A patent/NO20030033L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| UA72612C2 (en) | 2005-03-15 |
| HUP0301614A3 (en) | 2005-02-28 |
| HUP0301614A2 (hu) | 2003-09-29 |
| EP1303282A4 (fr) | 2004-04-07 |
| CZ20024052A3 (cs) | 2003-03-12 |
| KR20030032944A (ko) | 2003-04-26 |
| WO2002003997A1 (fr) | 2002-01-17 |
| NO20030033D0 (no) | 2003-01-03 |
| JP2004522694A (ja) | 2004-07-29 |
| US7081449B2 (en) | 2006-07-25 |
| IL151849A0 (en) | 2003-04-10 |
| MXPA02012156A (es) | 2004-08-19 |
| EP1303282A1 (fr) | 2003-04-23 |
| NZ521457A (en) | 2005-03-24 |
| CA2405798A1 (fr) | 2002-01-17 |
| AU7367001A (en) | 2002-01-21 |
| CN1440292A (zh) | 2003-09-03 |
| AU2001273670B2 (en) | 2005-07-14 |
| SK112003A3 (en) | 2003-04-01 |
| US20030144502A1 (en) | 2003-07-31 |
| ZA200208010B (en) | 2004-04-28 |
| BR0111531A (pt) | 2004-07-06 |
| PL359559A1 (en) | 2004-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20030033D0 (no) | Pyrido[2,3-D]pyrimidin- og pyrimido[4,5-D]pyrimidin- nukleosider | |
| NO20021694L (no) | Pyrazolo[4,3-d]pyrimidinderivater | |
| DE69915675D1 (de) | Triazolo[4,5-d]pyrimidin-derivate | |
| NO20022738L (no) | Pyrrolo(2,3-d)pyrimidinforbindelser | |
| DK1430057T3 (da) | Substituerede 2-pyridinyl-6,7,8, 9-tetrahydropyrimido [1,2-a] pyrimidin-4-on- og 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1H)onderivater | |
| DK1315731T3 (da) | 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on og 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1H)on-derivater | |
| NO20020931D0 (no) | Pyrrolo[2,3-d]pyrimidin-nukleosid-analoger | |
| DE50001191D1 (de) | Pyrazolo[4, 3-d]pyrimidine | |
| PL363077A1 (en) | Use of pyrazolo[4,3-d]pyrimidines | |
| PL361890A1 (en) | Use of pyrazolo[4,3-d]pyrimidines | |
| DE50106542D1 (de) | Substituierte 3,4-dihydro-pyrido[1,2-a]pyrimidine | |
| DE50106048D1 (de) | Substituierte 3,4-dihydro-pyrimido [1,2-a]pyrimidine und 3,4-dihydropyrazino [1,2-a]pyrimidine | |
| HK1054322A (en) | Pyrido[2,3-d] pyrimidine and pyrimido[4,5-d]pyrimidine nucleosides | |
| EP0904271A4 (fr) | 5,6,7,8-TETRAHYDROPYRIDO[2,3-d]PYRIMIDINES | |
| DK1326866T3 (da) | Substituerede 3,4-dihydro-pyrido[1,2-a]pyrimidiner |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |